LA HR90

Commends patients and the medical community for their efforts in fighting Adrenoleukodystrophy (ALD), a genetic condition that damages the myelin sheath covering nerve cells in the brain and spinal cord

Recognizes ALD as an inherited condition that affects males more severely, with symptoms often beginning between ages 4 and 10, including vision loss, learning disabilities, seizures, and progressive dementia

Acknowledges that ALD prevents the body from breaking down very long chain fatty acids, causing buildup in the brain, nervous system, and adrenal gland

Notes current treatments include medications, physical therapy, and stem cell transplants for patients diagnosed early in the condition's progression

Extends wishes that patients and medical professionals continue to receive support needed in their endeavors against ALD